Therefore, in the initial phase of sepsis, the anti-inflammatory therapy is effective and blocking the activity of IL-1β with biologic inhibitors has been used to prevent sepsis but showed limited effectiveness (Marshall, 2014). This evidence concerns the gene IL1B and Sepsis.